Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 134NIH 22INDUSTRY 21NETWORK 9OTHER_GOV 2INDIV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thoracic Neoplasms 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurologic Manifestations 1Neoplasms by Site 1Neoplasm Metastasis 1Myasthenia Gravis 1Mental Disorders 1Lung Neoplasms 1Lung Diseases 1Liver Neoplasms 1Head and Neck Neoplasms 1Early Stage Lung Cancer (I and II) 1Condylomata Acuminata 1Colonic Polyps 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Bronchogenic 1Cachexia 1Breast Neoplasms 1Anxiety Disorders 1Adenomatous Polyposis Coli 1

Interventions

Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × FED × Rectal Neoplasms × Clear all
NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡